Ann M. Powell is the global head of Human Resources and deeply committed to driving the company’s global capabilities in talent management, culture and organizational effectiveness while enabling an empowered workforce. She also currently serves as the executive sponsor of the Living Life Better company wellness program.
Ann partners across the company to foster an energized workforce and radically inclusive culture, where individuals are encouraged to exceed their potential and make innovative contributions for our patients and the global communities in which they live and work.
“At BMS, when we say we want people to bring their whole selves to work, we mean it. Courage, candor and inclusion fuel an innovative culture and, ultimately, a healthier future for all. I’m inspired every day by the courage and passion of our workforce as we work together to make a difference in patients’ lives,” says Ann.
Ann’s expertise includes executive compensation, shaping culture, talent development, change management, team effectiveness, inclusion, diversity, learning design and delivery, talent attraction, labor relations, mergers and acquisitions, divestitures and start-ups.
With a career spanning both international and domestic assignments, Ann has worked within the oil/gas, chemical and pharmaceutical industries, including Chevron, Dow and Wyeth Pharmaceuticals. Prior to joining Bristol Myers Squibb in 2013, Ann was the chief human resources officer for Shire Pharmaceuticals.
Ann earned a bachelor’s degree from Iowa State University and a master’s degree in labor and industrial relations from the University of Minnesota.
What is Ann Powell's net worth?
The estimated net worth of Ann Powell is at least $1.61 million as of August 24th, 2023. Ms. Powell owns 27,868 shares of Bristol-Myers Squibb stock worth more than $1,613,000 as of November 21st. This net worth approximation does not reflect any other investments that Ms. Powell may own. Learn More about Ann Powell's net worth.
How do I contact Ann Powell?
Has Ann Powell been buying or selling shares of Bristol-Myers Squibb?
Ann Powell has not been actively trading shares of Bristol-Myers Squibb during the last ninety days. Most recently, Ann Powell sold 17,986 shares of the business's stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $61.25, for a transaction totalling $1,101,642.50. Following the completion of the sale, the executive vice president now directly owns 27,868 shares of the company's stock, valued at $1,706,915. Learn More on Ann Powell's trading history.
Who are Bristol-Myers Squibb's active insiders?
Bristol-Myers Squibb's insider roster includes Mark Alles (CEO), Christopher Boerner (EVP), Giovanni Caforio (CEO), Adam Dubow (SVP), Joseph Eid (SVP), John Elicker (EVP), David Elkins (CFO), Samit Hirawat (EVP, Chief Medical Officer and Head of Development), Sandra Leung (EVP), Dinesh Paliwal (Director), Robert Plenge (EVP), Ann Powell (EVP), Theodore Samuels, II (Director), Karen Santiago (SVP), Louis Schmukler (EVP), Rupert Vessey (EVP), and Paul von Autenried (EVP). Learn More on Bristol-Myers Squibb's active insiders.
Are insiders buying or selling shares of Bristol-Myers Squibb?
During the last year, Bristol-Myers Squibb insiders bought shares 3 times. They purchased a total of 6,901 shares worth more than $349,655.16. During the last year, insiders at the biopharmaceutical company sold shares 1 times. They sold a total of 700 shares worth more than $38,934.00. The most recent insider tranaction occured on November, 4th when SVP Phil M Holzer sold 700 shares worth more than $38,934.00. Insiders at Bristol-Myers Squibb own 0.1% of the company.
Learn More about insider trades at Bristol-Myers Squibb. Information on this page was last updated on 11/4/2024.
